Prognostic factors of childhood and adolescent acute myeloid leukemia (AML) survival: Evidence from four decades of US population data

Cancer Epidemiology

Volumn 39, Issue 5, 2015, Pages 720-726

  Hossain, Md Jobayer ^a,b   Xie, Li ^a   Caywood, Emi H ^a  

^a NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

^b UNIVERSITY OF DELAWARE   (United States)

Author keywords

Acute myeloid leukemia; Heterogeneous; Prognostic factors; SEER; Stratified Cox proportional hazard model

Indexed keywords

ACUTE ERYTHROID LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ACUTE MYELOMONOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AFRICAN AMERICAN; ARTICLE; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURVIVAL; CAUCASIAN; CHILD; FEMALE; GEOGRAPHY; HIGH RISK POPULATION; HISPANIC; HUMAN; LEUKEMIA; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POPULATION RESEARCH; POVERTY; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; UNITED STATES; CANCER REGISTRY; GENETICS; INFANT; LEUKEMIA, MYELOID, ACUTE; PATHOLOGY; PRESCHOOL CHILD; PROGNOSIS; PROPORTIONAL HAZARDS MODEL;

ADOLESCENT; AFRICAN AMERICANS; CHILD; CHILD, PRESCHOOL; FEMALE; HISPANIC AMERICANS; HUMANS; INFANT; LEUKEMIA, MYELOID, ACUTE; MALE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SEER PROGRAM; UNITED STATES;

EID: 84941745335     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2015.06.009     Document Type: Article

References (30)

1. National Cancer Institute: PDQ® Childhood Acute Myeloid Leukemia/Other Myeloid Malignancies Treatment. Bethesda, MD: National Cancer Institute. Available from: (accessed 11.26.14.). http://cancer.gov/cancertopics/pdq/treatment/childAML/HealthProfessional.
2. Linabery A.M., Ross J.A. Trends in childhood cancer incidence in the U.S. (1992-2004). Cancer 2008, 112:416-432. 10.1002/cncr.23169.
3. Howlader N., Noone A.M., Krapcho M., et al. Seer Cancer Statistics Review 1975-2009 (Vintage 2009 Populations) 2012, MD: National Cancer Institute, Bethesda.
4. Fast Stats An interactive tool for access to SEER cancer statistics. Surveillance Research Program, National Cancer Institute. (accessed 4.01.15.). http://seer.cancer.gov/faststats.
5. Radhi M., Meshinchi S., Gamis A. Prognostic factors in pediatric acute myeloid leukemia. Curr. Hematol. Malig. Rep. 2010, 5(October (4)):200-206. 10.1007/s11899-010-0060-z.
6. Petridou E.T., Sergentanis T.N., Perlepe C., Papathoma P., Tsilimidos G., Kontogeorgi E., Kourti M., Baka M., Moschovi M., Polychronopoulou S., Sidi V., Hatzipantelis E., Stiakaki E., Iliadou A.N., La Vecchia C., Skalkidou A., Adami H. Socioeconomic disparities in survival from childhood leukemia in the United States and globally: a meta-analysis. Ann. Oncol. 2015, 26(March (3)):589-597. Epub 2014 December 19. 10.1093/annonc/mdu572.
7. Meshinchi S., Arceci R.J. Prognostic factors and risk-based therapy in pediatric acute myeloid leukemia. Oncologist 2007, 12(March (3)):341-355.
8. Davies S.M., Robison L.L., Buckley J.D., Tjoa T., Woods W.G., Radloff G.A., Ross J.A., Perentesis J.P. Glutathione S-transferase polymorphisms and outcome of chemotherapy in childhood acute myeloid leukemia. J. Clin. Oncol. 2001, 19(March (5)):1279-1287.
9. Damm F., Heuser M., Morgan M., Yun H., Grosshennig A., Göhring G., Schlegelberger B., Döhner K., Ottmann O., Lübbert M., Heit W., Kanz L., Schlimok G., Raghavachar A., Fiedler W., Kirchner H., Döhner H., Heil G., Ganser A., Krauter J. Single nucleotide polymorphism in the mutational hotspot of WT1 predicts a favorable outcome in patients with cytogenetically normal acute myeloid leukemia. J. Clin. Oncol. 2010, 28(Feburary (4)):578-585. Epub 2009 December 28. 10.1200/JCO.2009.23.0342.
10. Cancer Facts & Figures American Cancer Society 2014, American Cancer Society, Atlanta.
11. Bennett J.M., Catovsky D., Daniel M.T., Flandrin G., Galton D.A., Gralnick H.R., Sultan C. Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br. J. Haematol. 1976, 33(August (4)):451-458.
12. Vardiman J.W., Harris N.L., Brunning R.D. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood 2002, 100(October (7)):2292-2302.
13. Vardiman J.W., Thiele J., Arber D.A., Brunning R.D., Borowitz M.J., Porwit A., Harris N.L., Le Beau M.M., Hellström-Lindberg E., Tefferi A., Bloomfield C.D. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 2009, 114(July (5)):937-951. Epub 2009 April 8. 10.1182/blood-2009-03-209262.
14. Webb D.K., Harrison G., Stevens R.F., Gibson B.G., Hann I.M., Wheatley K. MRC childhood leukemia working party. Relationships between age at diagnosis, clinical features, and outcome of therapy in children treated in the Medical Research Council AML 10 and 12 trials for acute myeloid leukemia. Blood 2001, 98(September (6)):1714-1720.
15. Razzouk B.I., Estey E., Pounds S., Lensing S., Pierce S., Brandt M., Rubnitz J.E., Ribeiro R.C., Rytting M., Pui C.H., Kantarjian H., Jeha S. Impact of age on outcome of pediatric acute myeloid leukemia: a report from 2 instutions. Cancer 2006, 106(June (11)):2495-2502. 10.1002/cncr.21892.
16. Mistry A.R., Pedersen E.W., Solomon E., Grimwade D. The molecular pathogenesis of acute promyelocytic leukaemia: implications for the clinical management of the disease. Blood Rev. 2003, 17(June (2)):71-97.
17. Children's Oncology Group, Aplenc R., Alonzo T.A., Gerbing R.B., Smith F.O., Meshinchi S., Ross J.A., Perentesis J., Woods W.G., Lange B.J., Davies S.M. Ethnicity and survival in childhood acute myeloid leukemia: a report from the Children's Oncology Group. Blood 2006, 108(July (1)):74-80. Epub 2006 March 14.
18. Rubnitz J.E., Razzouk B.I., Lensing S., Pounds S., Pui C.H., Ribeiro R.C. Prognostic factors and outcome of recurrence in childhood acute myeloid leukemia. Cancer 2007, 109(January (1)):157-163.
19. Trueworthy R., Shuster J., Look T., Crist W., Borowitz M., Carroll A., Frankel L., Harris M., Wagner H., Haggard M. Ploidy of lymphoblasts is the strongest predictor of treatment outcome in B-progenitor cell acute lymphoblastic leukemia of childhood: a Pediatric Oncology Group study. J. Clin. Oncol. 1992, 10(April (4)):606-613.
20. SEER as a Research Resource, 2010, February. Retrieved November 26, 2014, from . http://seer.cancer.gov/about/factsheets/SEER_Research_Brochure.pdf.
21. Adamo M., Dickie L., Ruhl J. SEER Program Coding and Staging Manual 2015, National Cancer Institute, Bethesda, MD, 20850-9765, January 2015.
22. Creutzig U., Zimmermann M., Reinhardt D., Dworzak M., Stary J., Lehrnbecher T. Early deaths and treatment-related mortality in children undergoing therapy for acute myeloid leukemia: analysis of the multicenter clinical trials AML-BFM 93 and AML-BFM 98. J. Clin. Oncol. 2004, 22(November (21)):4384-4393.
23. Rubnitz J.E., Lensing S., Zhou Y., Sandlund J.T., Razzouk B.I., Ribeiro R.C., Pui C.H. Death during induction therapy and first remission of acute leukemia in childhood: the St. Jude experience. Cancer 2004, 101(October (7)):1677-1684.
24. Ruhl J., Adamo M., Dickie L. Hematopoietic And Lymphoid Neoplasm Coding Manual 2015, National Cancer Institute, Bethesda, MD, 20850-9765, January.
25. Lange B.J., Gerbing R.B., Feusner J., Skolnik J., Sacks N., Smith F.O., Alonzo T.A. Mortality in overweight and underweight children with acute myeloid leukemia. JAMA 2005, 293(January (2)):203-211.
26. Manola K.N. Cytogenetics of pediatric acute myeloid leukemia. Eur. J. Haematol. 2009, 83(November (5)):391-405. Epub 2009 June 25. 10.1111/j.1600-0609.2009.01308.x.
27. Creutzig U., van den Heuvel-Eibrink M.M., Gibson B., Dworzak M.N., Adachi S., de Bont E., Harbott J., Hasle H., Johnston D., Kinoshita A., Lehrnbecher T., Leverger G., Mejstrikova E., Meshinchi S., Pession A., Raimondi S.C., Sung L., Stary J., Zwaan C.M., Kaspers G.J., Reinhardt D. AML Committee of the International BFM Study Group. Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel. Blood 2012, 120(October (16)):3187-3205. Epub 2012 August 9. 10.1182/blood-2012-03-362608.
28. Mihova D., Zhang L. Acute erythroid leukemia: a review. N. Am. J. Med. Sci. 2012, 5(2):110-118.
29. Tarlock K., Meshinchi S. Pediatric acute myeloid leukemia: biology and therapeutic implications of genomic variants. Pediatr. Clin. North Am. 2015, 62(Feburary (1)):75-93. Epub 2014 October 29. 10.1016/j.pcl.2014.09.007.
30. Kayser S., Döhner K., Krauter J., Köhne C.H., Horst H.A., Held G., von Lilienfeld-Toal M., Wilhelm S., Kündgen A., Götze K., Rummel M., Nachbaur D., Schlegelberger B., Göhring G., Späth D., Morlok C., Zucknick M., Ganser A., Döhner H., Schlenk R.F. German-Austrian AMLSG. The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AML. Blood 2011, 117(Feburary (7)):2137-2145. Epub 2010 December 2. 10.1182/blood-2010-08-301713.